{"id":"14c-opc-167832","_chembl":{"chemblId":"CHEMBL4742102","moleculeType":"Unknown","molecularWeight":"421.59"},"modality":"Small molecule","_dailymed":null,"_scrapedAt":"2026-03-28T06:49:40.856Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_claudeStub":{"ts":1779123067,"model":"claude-sonnet-4-5-20250929"},"description":"[14C]-OPC-167832 is a radiolabeled investigational compound developed by Otsuka Pharmaceutical for Phase 1 clinical studies. The carbon-14 labeling enables tracking of drug metabolism and pharmacokinetics in early human trials to understand absorption, distribution, metabolism, and excretion pathways.","indications":{"approved":[{"status":"investigational","condition":"Unknown","patientPopulation":"Healthy volunteers or patients in Phase 1 studies"}]},"trialDetails":[],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"[14C]-OPC-167832","genericName":"[14C]-OPC-167832","companyName":"Otsuka Pharmaceutical Development & Commercialization, Inc.","companyId":"otsuka-pharmaceutical-development-commercialization-inc","firstApprovalDate":"","aiSummary":"There is limited information available on [14C]-OPC-167832, including its modality, as it is listed as \"Unknown\" in ChEMBL.","enrichmentLevel":2,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}